Pacific Biosciences Mean Deviation
| PACB Stock | | | USD 1.41 -0.24 -14.55% |
The mean deviation of the equity instrument is the first measure of the distances between each value of security historical prices and the mean. It gives us an idea of how spread out from the center the distribution of returns. Below is Pacific Biosciences's current Mean Deviation with peer comparisons and related risk metrics.
Current Mean Deviation Value
Pacific Biosciences has a Mean Deviation of 3.87, indicating moderate price variability. This places Pacific Biosciences within the typical volatility range for Life Sciences Tools & Services.
Mean Deviation | = | SUM(RET DEV)N |
| = | 3.87 | |
| SUM | = | Summation notation |
| RET DEV | = | Sum of return deviations of Pacific Biosciences |
| N | = | Number of calculation points for selected time horizon |
Mean Deviation Peers Comparison
Among sector peers, Pacific Biosciences's Mean Deviation of 3.87 is above the 3.86 group average. The range runs from 1.67 (Orthofix Medical) to 8.98 (POMDOCTOR LIMITED American). Pacific Biosciences has exhibited greater price dispersion than the peer average over the measured period.
Mean Deviation Relative To Other Indicators
The chart below plots Mean Deviation against Maximum Drawdown for Pacific Biosciences and its peers. Each point represents one equity — position along the horizontal axis shows Mean Deviation while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Pacific Biosciences's Maximum Drawdown of
18.41 runs about
4.76 times its Mean Deviation of
3.87 . This indicates Maximum Drawdown is significantly higher than Mean Deviation for Pacific Biosciences.
Methodology, Assumptions & Data Sources
Pacific Biosciences' Mean Deviation currently stands at 3.87. Mean Deviation for Pacific Biosciences is derived by applying a defined formula to historical price observations, producing a time-series of comparable readings. All inputs are based on exchange-reported closing prices, with adjustments for stock splits, dividends, and other corporate actions. Pacific Biosciences operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. Results are based on historical returns and do not predict future performance. This indicator is provided for informational purposes.
Other Technical Indicators